A rationale for combination therapy in risk factor management: a mechanistic perspective
- 31 December 2005
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 118 (12) , 54-61
- https://doi.org/10.1016/j.amjmed.2005.09.021
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery diseaseJournal of the American College of Cardiology, 2004
- Race-Specific Differences in Endothelial FunctionCirculation, 2004
- Effects of HMG-CoA Reductase Inhibitors on Endothelial FunctionCirculation, 2004
- Membrane Microdomains and Vascular BiologyCirculation, 2003
- Hypercholesterolemia and Hypertension Have Synergistic Deleterious Effects on Coronary Endothelial FunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- P1158 Synergistic stimulation of nitric oxide release from human endothelial cells with amlodipine and atorvastatinEuropean Heart Journal, 2003
- Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid AtherosclerosisCirculation, 2002
- Impaired endothelial function in arterial hypertension and hypercholesterolemiaJournal Of Hypertension, 2000
- Superoxide Anion Production Is Increased in a Model of Genetic HypertensionHypertension, 1999
- Membrane Antioxidant Effects of the Charged Dihydropyridine Calcium Antagonist AmlodipineJournal of Molecular and Cellular Cardiology, 1999